4//SEC Filing
Jones Timothy L. 4
Accession 0001493152-20-014581
CIK 0000849636other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 2:21 PM ET
Size
5.7 KB
Accession
0001493152-20-014581
Insider Transaction Report
Form 4
Jones Timothy L.
DirectorCEO and President
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2020-07-31+17,000,000→ 17,000,000 totalExercise: $0.01Exp: 2025-07-31→ Common Stock (17,000,000 underlying)
Footnotes (1)
- [F1]1,000,000 of these Common Stock Options were granted to Mr. Jones pursuant to his employment agreement, and vested upon issuance. The remaining 16,000,000 of these Common Stock Options were granted separately, and vest in four equal installments: 25 percent on July 31, 2020 (the grant date), 25 percent on September 30, 2020, 25 percent on December 31, 2020, and 25 percent on March 31, 2021.
Documents
Issuer
RespireRx Pharmaceuticals Inc.
CIK 0000849636
Entity typeother
Related Parties
1- filerCIK 0001812101
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 2:21 PM ET
- Size
- 5.7 KB